Investment
Features
FeesSafety
Academy
More
Pluang+

Compare A O Smith Corp (AOS) vs BIO-TECHNE Corp (TECH) Price & Performance

A O Smith CorpTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

A O Smith Corp vs BIO-TECHNE Corp — how do they compare? A O Smith Corp trades at $60.68 (market cap $8.33B), while BIO-TECHNE Corp trades at $71.44 (market cap $11.11B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and A O Smith Corp pays the higher dividend (2.35%). Which is the better fit depends on your goals.

AOSTECH
Market Cap
$8.33B$11.11B
Sector
IndustrialsHealth
52-Week High
$80.47$71.38
52-Week Low
$55.78$43.31
Enterprise Value
$8.78B$11.19B
Dividend Yield
2.35%0.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

A O Smith Corp

A.O. Smith (AOS) trades at $60.44, up 2.41% today, with a bearish technical signal despite recent leadership changes. The company reported mixed Q1 2026 earnings, missing EPS estimates at $0.85 versus $0.94 expected, while maintaining solid profitability with a 13.84% net margin. Cash flow trends show improving operations, and the stock offers a dividend with a recent $0.36 payout announced.

The outlook is cautious due to earnings volatility and bearish technicals, but valuation appears reasonable with a P/E of 16.12. Risks include China market weakness and competitive pressures, while analyst consensus leans hold with a $68 price target suggesting modest upside potential from current levels.

BIO-TECHNE Corp

Bio-Techne (TECH) trades at $71.30, up 0.21% today, near the $73.00 acquisition offer from Merck KGaA announced June 25, 2026. The stock shows bullish technical signals with moving averages supporting upside, while fundamentals reveal high valuation multiples (P/E 101.84) amid declining net margins (6.01% in 2025). Recent earnings were mixed with one beat and two misses in the last four quarters. Cash flow improved in 2026 projections, and the balance sheet remains solid with $152.86M cash.

The pending acquisition at $73.00 per share limits near-term upside but provides a floor. Risks include shareholder litigation questioning the deal's fairness and execution volatility. Analyst consensus is evenly split between Buy and Hold, with the price target slightly below current levels. The primary opportunity is the acquisition premium, while fundamental weakness in profitability poses a risk if the deal falters.

Returns comparison

Trailing returns across standard periods

About A O Smith Corp

A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells primarily to Asian countries and operates sales offices to expand distribution and market its product portfolio.

Read more on AOS

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH